International regulatory requirements for vaccine safety and potency testing: a WHO perspective&
Open Access
- 23 December 2011
- journal article
- Published by Elsevier in Procedia in Vaccinology
- Vol. 5, 164-170
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- WHO Working Group on technical specifications for manufacture and evaluation of dengue vaccines, Geneva, Switzerland, 11–12 May 2009Vaccine, 2010
- WHO Working Group on Technical Specifications for Manufacture and Evaluation of Yellow Fever Vaccines, Geneva, Switzerland, 13–14 May 2009Vaccine, 2010
- Massively parallel sequencing for monitoring genetic consistency and quality control of live viral vaccinesProceedings of the National Academy of Sciences, 2010
- Viral Nucleic Acids in Live-Attenuated Vaccines: Detection of Minority Variants and an Adventitious VirusJournal of Virology, 2010
- Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis virusesVaccine, 2010
- WHO informal consultation on the application of molecular methods to assure the quality, safety and efficacy of vaccines, Geneva, Switzerland, 7–8 April 2005Biologicals, 2007
- IABs scientific workshop on neurovirulence tests for live virus vaccines, January 31–February 1, 2005, GenevaBiologicals, 2006
- Microarray analysis of evolution of RNA viruses: Evidence of circulation of virulent highly divergent vaccine-derived poliovirusesProceedings of the National Academy of Sciences, 2003
- Quantitative mutant analysis of viral quasispecies by chip-based matrix-assisted laser desorption/ ionization time-of-flight mass spectrometryProceedings of the National Academy of Sciences, 2001
- Analysis of Mutations in Oral Poliovirus Vaccine by Hybridization with Generic Oligonucleotide MicrochipsBiologicals, 2000